The Breast Biopsy Market size was valued at USD 3.4 billion in 2024 and is set to exceed USD 7.71 billion by 2037, registering over 6.5% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of breast biopsy is estimated at USD 3.58 billion. The growth of the market is mainly due to the increasing cases of breast cancer. According to the World Health Organization (WHO), by the end of 2020, 711 million women had been diagnosed with breast cancer in the past 5 years, making it the most common cancer in the world.
In addition, government initiatives around the world to develop and implement new screening programs, raise awareness of treatment options, and organize free camps are expected to be the main driving force for the development of the global market.
Growth Driver
Challenges
Base Year |
2024 |
Forecast Year |
2025-2037 |
CAGR |
6.5% |
Base Year Market Size (2024) |
USD 3.4 billion |
Forecast Year Market Size (2037) |
USD 7.71 billion |
Regional Scope |
|
End Users (Hospitals, Ambulatory Surgical Centers, Diagnostic Centers)
The hospital segment in the breast biopsy market is estimated to hold the largest revenue share around 40% between the time period 2023 – 2037. The growth of this segment can be attributed to the large number of patients requiring breast biopsies and hospitalization for surgery or treatment. Hospitals are also experiencing remarkable growth in numbers. For example, in 2022, there are about 6,100 hospitals in the United States. Hospitals provide a wide range of medical care services. Doctors, called hospital physicians, often specialize in internal medicine, pediatrics, or general medicine. They know to solve common problems and have the resources to tackle more complex medical problems.
Product (Biopsy Needles, Biopsy Tables, Biopsy Wires)
The biopsy needle segment is set to hold 30% share of the global breast biopsy market by the end of 2037. The growth of this segment can be attributed to the increasing demand for breast biopsy procedures, including the use of biopsy needles. The growing awareness of the importance of breast biopsy procedures, including the use of biopsy needles.
Our in-depth analysis of the global market includes the following segments:
Product |
|
End User |
|
APAC Market Forecast
The breast biopsies market in Asia Pacific, is expected to hold the largest revenue share of around 35% by the end of 2037. The growth of the region is likely to be mainly due to the increase in the percentage of the aging population in the Asia Pacific region. As older women have a higher risk of breast cancer. Also, health organizations are increasingly promoting breast cancer screening programs, including mammograms and breast biopsies.
North America Market Statistics
The breast biopsy market in the North America is expected to account for the second largest market share, around 25% during the projection period. The growth of the market in this region can be mainly attributed to the increasing technological advancement in breast biopsy technology in North America. There have been significant advances in the design and function of biopsy needles and other biopsy devices in North America, making breast biopsies more precise and less invasive. This has led to an increase in demand for breast biopsy procedures in the region. All insurance plans in North America cover breast biopsy procedures, making the procedure easier for patients to access, leading to increased demand
Author Credits: Radhika Pawar
Copyright © 2024 Research Nester. All Rights Reserved
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?